US Bancorp’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,329
Closed -$1K 4306
2022
Q3
$1K Sell
3,329
-10,777
-76% -$5.62K ﹤0.01% 4033
2022
Q2
$6K Sell
14,106
-13,626
-49% -$6.08K ﹤0.01% 3557
2022
Q1
$17K Buy
27,732
+13,886
+100% +$10.7K ﹤0.01% 3174
2021
Q4
$15K Buy
13,846
+3,830
+38% +$5.92K ﹤0.01% 3284
2021
Q3
$19K Buy
+10,016
New +$22.5K ﹤0.01% 3166
2019
Q3
Sell
-1,029
Closed -$18K 3695
2019
Q2
$18K Buy
1,029
+365
+55% +$7.99K ﹤0.01% 2929
2019
Q1
$21K Sell
664
-696
-51% -$23.3K ﹤0.01% 2845
2018
Q4
$40K Sell
1,360
-722
-35% -$32.8K ﹤0.01% 2548
2018
Q3
$157K Buy
2,082
+1,313
+171% +$88.8K ﹤0.01% 1995
2018
Q2
$44K Buy
769
+734
+2,097% +$26.7K ﹤0.01% 2641
2018
Q1
$1K Hold
35
﹤0.01% 3567
2017
Q4
$1K Hold
35
﹤0.01% 3561
2017
Q3
$1K Hold
35
﹤0.01% 3522
2017
Q2
$0 Hold
35
﹤0.01% 3625
2017
Q1
$1K Hold
35
﹤0.01% 3496
2016
Q4
$1K Hold
35
﹤0.01% 3479
2016
Q3
$1K Sell
35
-77
-69% -$1.41K ﹤0.01% 3482
2016
Q2
$2K Buy
+112
New +$3.52K ﹤0.01% 3412

Other funds holding ASXC

US Bancorp's ASXC Position: Q4 2022 in Review

US Bancorp sold out of Asensus Surgical, Inc. (ASXC) in Q4 2022, closing a stake of 3,329 shares — an estimated $1K sold.

US Bancorp first reported a position in ASXC in Q2 2016 and held it in 18 quarters. The position peaked at $157K in Q3 2018. 74 funds tracked by Wall St. Rank hold ASXC as of Q4 2022.

  • US Bancorp reported no remaining Asensus Surgical, Inc. position as of Q4 2022 after selling out during the quarter.
  • US Bancorp sold 3,329 Asensus Surgical, Inc. shares in Q4 2022, an estimated $1K.
  • US Bancorp first reported a position in Asensus Surgical, Inc. in Q2 2016 and held it in 18 quarters.
  • US Bancorp's Asensus Surgical, Inc. position peaked at $157K in Q3 2018.
  • 74 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2022.

Based on US Bancorp's 13F filing for Q4 2022, filed 13 Feb 2023.